The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome
- PMID: 35522394
- DOI: 10.1007/s12325-022-02146-w
The Impact of a Prenatal Education Program for Opioid-Dependent Mothers on Breastfeeding Rates of Infants at Risk for Neonatal Abstinence Syndrome
Abstract
Introduction: This study aimed to determine the effect of a prenatal education program for opioid-dependent women on breastfeeding frequency, newborn hospital length of stay, and cost of care for neonates at risk of developing neonatal abstinence syndrome.
Methods: From January 1, 2015 to January 1, 2020, opioid-dependent obstetric patients were educated on non-pharmacological preventative measures for neonatal abstinence syndrome (NAS), with focused counseling on breastfeeding. Data were collected and compared to a control group of opioid-dependent pregnant women who received standard care before initiation of the education program.
Results: Sample size calculation revealed that to detect doubling of the breastfeeding rate from 25% to 50% with 80% power and α error of 0.05, 66 participants were required in each group.
Conclusion: There were 75 women with opioid use disorder who had prenatal NAS education (study group) and 108 women with opioid use disorder who underwent standard care before NAS education (control group). Prenatal NAS education participants significantly increased breastfeeding initiation rates compared to the control group. Newborn length of stay significantly decreased after initiation of prenatal NAS education compared to the 36 months before NAS education program.
Keywords: Breastfeeding; Neonatal abstinence syndrome; Newborn; Opioid-dependent; Prenatal.
© 2022. The Author(s), under exclusive licence to Springer Healthcare Ltd., part of Springer Nature.
Similar articles
-
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009. J Midwifery Womens Health. 2013. PMID: 23931660
-
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.BMC Health Serv Res. 2023 May 6;23(1):448. doi: 10.1186/s12913-023-09440-5. BMC Health Serv Res. 2023. PMID: 37149626 Free PMC article.
-
Breastfeeding promotion for management of neonatal abstinence syndrome.J Obstet Gynecol Neonatal Nurs. 2013 Sep-Oct;42(5):517-26. doi: 10.1111/1552-6909.12242. Epub 2013 Sep 4. J Obstet Gynecol Neonatal Nurs. 2013. PMID: 24020477 Review.
-
Prenatal Breastfeeding Education: Impact on Infants With Neonatal Abstinence Syndrome.Adv Neonatal Care. 2017 Aug;17(4):299-305. doi: 10.1097/ANC.0000000000000392. Adv Neonatal Care. 2017. PMID: 28244941
-
Breastfeeding Considerations for Mothers of Infants with Neonatal Abstinence Syndrome.Pharmacotherapy. 2017 Jul;37(7):861-869. doi: 10.1002/phar.1944. Epub 2017 Jun 22. Pharmacotherapy. 2017. PMID: 28488805 Review.
Cited by
-
A phase I pilot study of a mobile education tool for supporting pregnant women with opioid use disorder.Drug Alcohol Depend Rep. 2025 Mar 26;15:100327. doi: 10.1016/j.dadr.2025.100327. eCollection 2025 Jun. Drug Alcohol Depend Rep. 2025. PMID: 40236622 Free PMC article.
-
Development of an Educational Brochure about Treatment Options for Pregnant Women with Opioid Use Disorders.Pharmacy (Basel). 2024 Jun 22;12(4):97. doi: 10.3390/pharmacy12040097. Pharmacy (Basel). 2024. PMID: 39051381 Free PMC article.
-
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.J Pers Med. 2022 Dec 6;12(12):2015. doi: 10.3390/jpm12122015. J Pers Med. 2022. PMID: 36556236 Free PMC article. Review.
-
Breastfeeding Experiences in Women from Ten States Reporting Opioid Use Before or During Pregnancy: PRAMS, Phase 8.Matern Child Health J. 2023 Apr;27(4):747-756. doi: 10.1007/s10995-022-03497-0. Epub 2022 Aug 10. Matern Child Health J. 2023. PMID: 35947276
References
-
- Patrick SW. A comprehensive approach to the opioid epidemic. Obstet Gynecol. 2017;130(1):7–9. https://doi.org/10.1097/AOG.0000000000002118 . - DOI - PubMed
-
- Paulozzi LJ, Mack KA, Hockenberry JM, Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazepines—United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;26(63):563–568. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6326a2.htm .
-
- Desai RJ, Hernandez-Diaz S, Bateman BT, Huybrechts KF. Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002. https://doi.org/10.1097/AOG.0000000000000208 . - DOI - PubMed - PMC
-
- Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009–2012. J Perinatol. 2015;35(8):650–5. https://doi.org/10.1038/jp.2015.36 . - DOI - PubMed - PMC
-
- Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. JAMA. 2012;307(18):1934–40. https://doi.org/10.1001/jama.2012.3951 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
